The global rare neurodegenerative disease treatment market is currently estimated to be US$ 72.9 billion and likely to reach US$ 119.2 billion by the end of 2033. During this time, the growth rate would track a CAGR of 5% over the next ten years. Steady growth for these would be due to various key factors, such as growing investments in research and development and rising awareness of...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek